Karin Hellsvik - Foghorn TherapeuticsInc Corporate VP
| FHTX Stock | USD 6.22 0.22 3.67% |
VP
Karin Hellsvik is Corporate VP of Foghorn TherapeuticsInc
| Address | 500 Technology Square, Cambridge, MA, United States, 02139 |
| Phone | 617 586 3100 |
| Web | https://foghorntx.com |
Foghorn TherapeuticsInc Management Efficiency
The company has return on total asset (ROA) of (0.2046) % which means that it has lost $0.2046 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.7038) %, meaning that it created substantial loss on money invested by shareholders. Foghorn TherapeuticsInc's management efficiency ratios could be used to measure how well Foghorn TherapeuticsInc manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 1.34 in 2024, whereas Return On Tangible Assets are likely to drop (0.36) in 2024. At this time, Foghorn TherapeuticsInc's Debt To Assets are fairly stable compared to the past year. Fixed Asset Turnover is likely to rise to 0.84 in 2024, whereas Total Assets are likely to drop slightly above 280.8 M in 2024.Similar Executives
| Found 1 records | VP Age | ||
| Nicholas Maestas | Tempest Therapeutics | 44 | |
Management Performance
| Return On Equity | -4.7 | ||||
| Return On Asset | -0.2 |
Foghorn TherapeuticsInc Leadership Team
Elected by the shareholders, the Foghorn TherapeuticsInc's board of directors comprises two types of representatives: Foghorn TherapeuticsInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Foghorn. The board's role is to monitor Foghorn TherapeuticsInc's management team and ensure that shareholders' interests are well served. Foghorn TherapeuticsInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Foghorn TherapeuticsInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Saurabh Sewak, Vice Development | ||
| Karin Hellsvik, Corporate VP | ||
| Adrian Gottschalk, CEO President | ||
| Stephen DiPalma, Treasurer CFO | ||
| Allan MD, Chief Officer | ||
| Alfonso MD, Chief Officer | ||
| Gerald Md, Founder Board | ||
| Fanny Cavalie, Chief Officer | ||
| Carlos Costa, Chief Officer | ||
| Ben Strain, VP Communications | ||
| Michael LaCascia, Chief Officer | ||
| Steven Bellon, Chief Officer | ||
| MPH MD, Chief Officer |
Foghorn Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Foghorn TherapeuticsInc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.7 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | (2.74) % | ||||
| Operating Margin | (5.58) % | ||||
| Current Valuation | 101.2 M | ||||
| Shares Outstanding | 42.59 M | ||||
| Shares Owned By Insiders | 19.07 % | ||||
| Shares Owned By Institutions | 47.94 % | ||||
| Number Of Shares Shorted | 1.32 M | ||||
| Price To Book | 10.71 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Foghorn TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Foghorn TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Foghorn Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Foghorn Therapeuticsinc Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Foghorn TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn TherapeuticsInc guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Foghorn Stock analysis
When running Foghorn TherapeuticsInc's price analysis, check to measure Foghorn TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn TherapeuticsInc is operating at the current time. Most of Foghorn TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Foghorn TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn TherapeuticsInc's price. Additionally, you may evaluate how the addition of Foghorn TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Foghorn TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Foghorn TherapeuticsInc. If investors know Foghorn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Foghorn TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.20) | Revenue Per Share 0.805 | Quarterly Revenue Growth (0.05) | Return On Assets (0.20) | Return On Equity (4.70) |
The market value of Foghorn TherapeuticsInc is measured differently than its book value, which is the value of Foghorn that is recorded on the company's balance sheet. Investors also form their own opinion of Foghorn TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Foghorn TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Foghorn TherapeuticsInc's market value can be influenced by many factors that don't directly affect Foghorn TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Foghorn TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Foghorn TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Foghorn TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.